Cargando…

Coronavirus Disease 2019–Associated Invasive Fungal Infection

Coronavirus disease 2019 (COVID-19) can become complicated by secondary invasive fungal infections (IFIs), stemming primarily from severe lung damage and immunologic deficits associated with the virus or immunomodulatory therapy. Other risk factors include poorly controlled diabetes, structural lung...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baddley, John W, Thompson, George R, Chen, Sharon C -A, White, P Lewis, Johnson, Melissa D, Nguyen, M Hong, Schwartz, Ilan S, Spec, Andrej, Ostrosky-Zeichner, Luis, Jackson, Brendan R, Patterson, Thomas F, Pappas, Peter G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643686/ https://www.ncbi.nlm.nih.gov/pubmed/34877364 http://dx.doi.org/10.1093/ofid/ofab510

Ejemplares similares

Balancing Scientific Rigor With Urgency in the Coronavirus Disease 2019 Pandemic
por: Spec, Andrej, et al.
Publicado: (2020)

Real-world Use of Mold-Active Triazole Prophylaxis in the Prevention of Invasive Fungal Diseases: Results From a Subgroup Analysis of a Multicenter National Registry
por: Nguyen, M Hong, et al.
Publicado: (2023)

Prevention and Treatment of Yeast and Endemic Fungal Infections
por: Al Hammadi, Ahmed, et al.
Publicado: (2019)

Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
por: Thompson, George R, et al.
Publicado: (2022)

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases
por: Revankar, Sanjay G, et al.
Publicado: (2017)

Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies
por: Clancy, Cornelius J, et al.
Publicado: (2021)

Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data Analysis
por: Al-Obaidi, Mohanad M, et al.
Publicado: (2023)

Management of Histoplasmosis by Infectious Disease Physicians
por: Mazi, Patrick B, et al.
Publicado: (2022)

Invasive Mold Infections Following Hurricane Harvey—Houston, Texas
por: Toda, Mitsuru, et al.
Publicado: (2023)

End-Stage Liver Disease Is a Strong Predictor of Early Mortality in Cryptococcosis
por: Spec, Andrej, et al.
Publicado: (2015)

Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections
por: Kubin, Christine J, et al.
Publicado: (2021)

Post–Lung Transplantation Outcomes and Ex Vivo Histopathological Findings in Severe Post-Covid-19 Pulmonary Disease—A Single-Center Experience
por: Javaid, Hana, et al.
Publicado: (2022)

Long-term Outcomes of Patients With Fungal Infections Associated With Contaminated Methylprednisolone Injections
por: Malani, Anurag N, et al.
Publicado: (2020)

Creation and Assessment of a Clinical Predictive Calculator and Mortality Associated With Candida krusei Bloodstream Infections
por: Kronen, Ryan, et al.
Publicado: (2018)

Hospital-Acquired Bloodstream Infections in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019): Association With Immunosuppressive Therapies
por: Khatri, Akshay, et al.
Publicado: (2021)

Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections
por: Ostrosky-Zeichner, L., et al.
Publicado: (2022)

Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019
por: Hakre, Shilpa, et al.
Publicado: (2022)

Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston (2012–2017)
por: Al-Obaidi, Mohanad, et al.
Publicado: (2019)

Dying at Home Due to Coronavirus Disease 2019
por: Edwards, Jessie K, et al.
Publicado: (2022)

Testing for Cryptococcosis at a Major Commercial Laboratory—United States, 2019–2021
por: Benedict, Kaitlin, et al.
Publicado: (2022)

Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study
por: Atallah, Natalie J, et al.
Publicado: (2022)

1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI)
por: Alexander, Barbara D, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020–May 2021
por: Couture, Alexia, et al.
Publicado: (2022)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

Extensively Drug-Resistant Pseudomonas aeruginosa ST309 Harboring Tandem Guiana Extended Spectrum β-Lactamase Enzymes: A Newly Emerging Threat in the United States
por: Khan, Ayesha, et al.
Publicado: (2019)

Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
por: Mozaffari, Essy, et al.
Publicado: (2021)

Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region
por: Strathdee, Steffanie A, et al.
Publicado: (2021)

Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay( )
por: Sigal, George B, et al.
Publicado: (2022)

Development of a Standardized Data Collection Tool for Evaluation and Management of Coronavirus Disease 2019
por: Morris, Stephen R, et al.
Publicado: (2020)

Myocarditis Following Coronavirus Disease 2019 mRNA Vaccine: A Case Series and Incidence Rate Determination
por: Perez, Yalile, et al.
Publicado: (2021)

Coronavirus Disease 2019 Vaccination Is Associated With Reduced Outpatient Antibiotic Prescribing in Older Adults With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2: A Population-Wide Cohort Study
por: MacFadden, Derek R, et al.
Publicado: (2023)

Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
por: Mandell, Lionel A, et al.
Publicado: (2022)

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate
por: Clancy, Cornelius J, et al.
Publicado: (2022)

Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events
por: Wiemken, Timothy L, et al.
Publicado: (2022)

Protocol-Driven Intensive Outpatient Management of Pregnant Patients With Symptomatic Coronavirus Disease 2019
por: Soffer, M D, et al.
Publicado: (2020)

AIDS-Defining Illnesses at Initial Diagnosis of HIV in a Large Guatemalan Cohort
por: Reinhardt, Samuel W, et al.
Publicado: (2017)

Creation and Internal Validation of a Clinical Predictive Model for Fluconazole Resistance in Patients With Candida Bloodstream Infection
por: Rauseo, Adriana M, et al.
Publicado: (2022)

Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019( )
por: Castanha, Priscila M S, et al.
Publicado: (2022)

350. Clinical impact of positive fungal blood cultures for diagnosis and treatment of fungal infections.
por: Chavez, Miguel A, et al.
Publicado: (2022)

Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone
por: Virk, Abinash, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tvaba4i2mg04si3o8ms968e085